COR Cencora Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
23:44
Jul 01
Jul 01
CNBC
Health insurers and drug distributors are undervalued.
Health insurers and drug distributors deserve to trade higher. Cardinal Health had a great quarter obscured by sector rotation, and CVS gains will be long-lasting.
COR
Cencora
Long
2ND
—
—
08:14
Jun 10
Jun 10
r/ValueInvesting
Cencora (COR) is classified as a Fast Grower, PEG 0.64, and 22% below fair value.
Cencora (COR) is classified as a Fast Grower, PEG 0.64, and 22% below fair value. The combined Lynch/Soros signal suggests the market is overreacting to temporary headwinds, leaving growth priced in at a discount. A classic value/growth crossover – high earnings growth at a low multiple, with sentiment providing extra margin of safety. Drug pricing pressure, supply chain disruptions, or consolidation in pharma distribution.
COR
Cencora
Long
1ST
—
—
13:00
Apr 24
Apr 24
The Compound News
Cencora favored for AI margin gains
Named in answer to 'which names do you like?' within his bullish healthcare view: labor-heavy, low-margin healthcare businesses with steady demand stand to expand margins through AI productivity.
COR
Cencora
Long
—
—
About COR Investor Commentary
Across the available history and selected sources, Buzzberg tracks COR (Cencora) across 9 sources: 6 bullish vs 0 bearish calls from 11 authors. Historical directional balance: 40% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 15 total trade ideas tracked. Past 7 days, before deduplication: 3 other directions. Latest voices: Jim Cramer, u/ClearValue1994, Adam Parker.